Detalhe da pesquisa
1.
Nabiximols discontinuation rate in a large population of patients with multiple sclerosis: a 18-month multicentre study.
J Neurol Neurosurg Psychiatry;
91(9): 914-920, 2020 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32661083
2.
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study.
Neurol Sci;
41(10): 2905-2913, 2020 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32335779
3.
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study.
Mult Scler;
25(9): 1263-1272, 2019 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30044207
4.
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis.
J Neurol Neurosurg Psychiatry;
89(12): 1272-1278, 2018 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29970387
5.
Attention-related changes in short-term cortical plasticity help to explain fatigue in multiple sclerosis.
Mult Scler;
22(10): 1359-66, 2016 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26672995
6.
Human polyomavirus JC replication and non-coding control region analysis in multiple sclerosis patients under natalizumab treatment.
J Neurovirol;
21(6): 653-65, 2015 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25930159
7.
From high- to low-frequency administered interferon-beta for multiple sclerosis: a multicenter study.
Eur Neurol;
71(5-6): 233-41, 2014.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24480868
8.
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.
Virol J;
10: 298, 2013 Sep 30.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24079660
9.
Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI study.
Mult Scler;
17(10): 1177-84, 2011 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21677022
10.
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study.
J Neurol;
267(3): 694-702, 2020 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31720848
11.
Cladribine vs other drugs in MS: Merging randomized trial with real-life data.
Neurol Neuroimmunol Neuroinflamm;
7(6)2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32801167
12.
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study.
Mult Scler Relat Disord;
42: 102059, 2020 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32208344
13.
H-magnetic resonance spectroscopy: diagnostic tool in recurrent headache in systemic lupus erythematosus. A case report.
Radiol Case Rep;
14(2): 175-178, 2019 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30425768
14.
Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis.
Open Forum Infect Dis;
6(1): ofy356, 2019 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30697576
15.
Dynamic changes of MMP-9 plasma levels correlate with JCV reactivation and immune activation in natalizumab-treated multiple sclerosis patients.
Sci Rep;
9(1): 311, 2019 01 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30670793
16.
JC Virus-DNA Detection Is Associated with CD8 Effector Accumulation in Peripheral Blood of Patients with Multiple Sclerosis under Natalizumab Treatment, Independently from JC Virus Serostatus.
Biomed Res Int;
2018: 5297980, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29682547
17.
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study.
J Neurol;
265(12): 2851-2860, 2018 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30259178
18.
Fingolimod vs dimethyl fumarate in multiple sclerosis: A real-world propensity score-matched study.
Neurology;
91(2): e153-e161, 2018 07 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29875218
19.
Screening of a microvascular endothelial cDNA library identifies rabaptin 5 as a novel autoantigen in Alzheimer's disease.
J Neuroimmunol;
192(1-2): 105-12, 2007 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17961730
20.
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis.
J Neurol;
264(2): 284-294, 2017 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27878443